Rubicon Organics Stock Net Income
| ROMJF Stock | USD 0.34 0.02 6.25% |
As of the 27th of January, Rubicon Organics holds the Risk Adjusted Performance of (0.02), variance of 14.31, and Coefficient Of Variation of (2,760). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rubicon Organics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We are able to break down thirteen technical drivers for Rubicon Organics, which can be compared to its competitors. Please check Rubicon Organics mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Rubicon Organics is priced some-what accurately, providing market reflects its current price of 0.34 per share. As Rubicon Organics appears to be a penny stock we also advise to check out its jensen alpha numbers.
Rubicon Organics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Rubicon Organics' valuation are provided below:Rubicon Organics does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Rubicon |
Rubicon Organics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rubicon Organics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rubicon Organics.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Rubicon Organics on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Rubicon Organics or generate 0.0% return on investment in Rubicon Organics over 90 days. Rubicon Organics is related to or competes with Charlottes Web, Avicanna, and High Sierra. Rubicon Organics Inc. produces and sells organic cannabis for the recreational and medical-use markets in Canada More
Rubicon Organics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rubicon Organics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rubicon Organics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 18.25 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 5.88 |
Rubicon Organics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rubicon Organics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rubicon Organics' standard deviation. In reality, there are many statistical measures that can use Rubicon Organics historical prices to predict the future Rubicon Organics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.27) |
Rubicon Organics January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.26) | |||
| Mean Deviation | 2.71 | |||
| Coefficient Of Variation | (2,760) | |||
| Standard Deviation | 3.78 | |||
| Variance | 14.31 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.27) | |||
| Maximum Drawdown | 18.25 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 5.88 | |||
| Skewness | 0.0605 | |||
| Kurtosis | 0.4236 |
Rubicon Organics Backtested Returns
Rubicon Organics maintains Sharpe Ratio (i.e., Efficiency) of -0.0437, which implies the firm had a -0.0437 % return per unit of risk over the last 3 months. Rubicon Organics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rubicon Organics' Risk Adjusted Performance of (0.02), coefficient of variation of (2,760), and Variance of 14.31 to confirm the risk estimate we provide. The company holds a Beta of 0.55, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Rubicon Organics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Rubicon Organics is expected to be smaller as well. At this point, Rubicon Organics has a negative expected return of -0.17%. Please make sure to check Rubicon Organics' jensen alpha and the relationship between the potential upside and period momentum indicator , to decide if Rubicon Organics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.03 |
Very weak reverse predictability
Rubicon Organics has very weak reverse predictability. Overlapping area represents the amount of predictability between Rubicon Organics time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rubicon Organics price movement. The serial correlation of -0.03 indicates that only 3.0% of current Rubicon Organics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Rubicon Organics reported net income of (14.52 Million). This is 104.25% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 102.54% higher than that of the company.
Rubicon Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rubicon Organics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Rubicon Organics could also be used in its relative valuation, which is a method of valuing Rubicon Organics by comparing valuation metrics of similar companies.Rubicon Organics is currently under evaluation in net income category among its peers.
Rubicon Fundamentals
| Return On Equity | -0.0569 | |||
| Return On Asset | -0.0117 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 29.99 M | |||
| Shares Outstanding | 56.08 M | |||
| Shares Owned By Insiders | 54.29 % | |||
| Shares Owned By Institutions | 1.33 % | |||
| Price To Earning | 5.86 X | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 0.89 X | |||
| Revenue | 22.61 M | |||
| Gross Profit | 1.51 M | |||
| EBITDA | (10.87 M) | |||
| Net Income | (14.52 M) | |||
| Cash And Equivalents | 7.42 M | |||
| Cash Per Share | 0.13 X | |||
| Total Debt | 8.95 M | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 3.75 X | |||
| Book Value Per Share | 0.73 X | |||
| Cash Flow From Operations | (10.44 M) | |||
| Earnings Per Share | (0.17) X | |||
| Number Of Employees | 141 | |||
| Beta | 0.82 | |||
| Market Capitalization | 30.56 M | |||
| Total Asset | 54.84 M | |||
| Z Score | 1.8 | |||
| Net Asset | 54.84 M |
About Rubicon Organics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rubicon Organics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rubicon Organics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rubicon Organics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Rubicon OTC Stock
Rubicon Organics financial ratios help investors to determine whether Rubicon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rubicon with respect to the benefits of owning Rubicon Organics security.